We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Univar (UNVR) Boosts Portfolio With Grace's SYLOID FP Silica
Read MoreHide Full Article
Univar Solutions Inc. has announced an agreement with W. R. Grace & Co. to distribute Grace's SYLOID FP silica in the pharmaceutical and nutraceutical markets across most European countries. This agreement expands upon the existing global partnership between Univar Solutions and Grace that already covers the United States, Brazil, Mexico, and the majority of Europe.
Grace's SYLOID FP silica is a highly efficient and versatile excipient used in pharmaceutical and nutraceutical applications. It effectively addresses challenges related to powder flow and caking. This engineered hydrated silicon dioxide is produced under controlled conditions and meets various regulatory requirements. With high chemical purity and performance, SYLOID FP silica offers multiple benefits in formulations.
The excipient is easy to incorporate and provides optimal performance as a glidant, a carrier for active ingredients, tableting aid, a thickener, and a disintegrant. It improves the handling, adsorption, and dissolution of pharmaceuticals and nutraceuticals. By utilizing SYLOID FP silica, the number of excipients needed in formulations can be minimized, simplifying the manufacturing process. This ultimately enhances the efficacy of the final dosage form by improving its overall performance.
Univar Solutions has gained 25.4% in the past year compared with the industry’s 0.8% rise in the same period.
Image Source: Zacks Investment Research
Univar entered into a definitive agreement, to be acquired by Apollo Funds for approximately $8.1 billion in an all-cash transaction in March 2023. UNVR’s shareholders will receive $36.15 per share in cash for every share of the company’s common stock under the deal terms. The acquisition has received approval from Univar shareholders, as well as antitrust regulatory approvals from the United States, Brazil, Canada, China, the EU, and Mexico, along with foreign direct investment approval from Italy. Regulatory approvals are pending in Turkey. Foreign direct investment approvals from the United States (Committee on Foreign Investment), France and Spain are also needed. Univar expects the transaction to close in the third quarter of 2023, subject to the fulfilment of all necessary conditions.
Zacks Rank & Key Picks
The company currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for L.B. Foster’s current-year earnings has been revised 47.4% upward in the past 60 days. The consensus estimate for current-year earnings for FSTR is currently pegged at 53 cents, indicating year-over-year growth of 112.5%. The company’s shares have popped around 12% over the past year. FSTR beat the Zacks Consensus Estimate in all the last four quarters. It delivered a trailing four-quarter earnings surprise of 140.5%, on average.
The Zacks Consensus Estimate for Koppers’ current-year earnings is currently pegged at $4.40, implying year-over-year growth of 6.3%. It delivered a trailing four-quarter earnings surprise of roughly 13.64%, on average. Shares of KOP have gained 32% in a year.
The Zacks Consensus Estimate for Linde’s current-year earnings has been revised 5.1% upward in the past 60 days. LIN beat the Zacks Consensus Estimate in all the last four quarters, with an average earnings surprise being 6.9%. The company’s shares have gained 22.5% in the past year.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Univar (UNVR) Boosts Portfolio With Grace's SYLOID FP Silica
Univar Solutions Inc. has announced an agreement with W. R. Grace & Co. to distribute Grace's SYLOID FP silica in the pharmaceutical and nutraceutical markets across most European countries. This agreement expands upon the existing global partnership between Univar Solutions and Grace that already covers the United States, Brazil, Mexico, and the majority of Europe.
Grace's SYLOID FP silica is a highly efficient and versatile excipient used in pharmaceutical and nutraceutical applications. It effectively addresses challenges related to powder flow and caking. This engineered hydrated silicon dioxide is produced under controlled conditions and meets various regulatory requirements. With high chemical purity and performance, SYLOID FP silica offers multiple benefits in formulations.
The excipient is easy to incorporate and provides optimal performance as a glidant, a carrier for active ingredients, tableting aid, a thickener, and a disintegrant. It improves the handling, adsorption, and dissolution of pharmaceuticals and nutraceuticals. By utilizing SYLOID FP silica, the number of excipients needed in formulations can be minimized, simplifying the manufacturing process. This ultimately enhances the efficacy of the final dosage form by improving its overall performance.
Univar Solutions has gained 25.4% in the past year compared with the industry’s 0.8% rise in the same period.
Image Source: Zacks Investment Research
Univar entered into a definitive agreement, to be acquired by Apollo Funds for approximately $8.1 billion in an all-cash transaction in March 2023. UNVR’s shareholders will receive $36.15 per share in cash for every share of the company’s common stock under the deal terms. The acquisition has received approval from Univar shareholders, as well as antitrust regulatory approvals from the United States, Brazil, Canada, China, the EU, and Mexico, along with foreign direct investment approval from Italy. Regulatory approvals are pending in Turkey. Foreign direct investment approvals from the United States (Committee on Foreign Investment), France and Spain are also needed. Univar expects the transaction to close in the third quarter of 2023, subject to the fulfilment of all necessary conditions.
Zacks Rank & Key Picks
The company currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks to consider in the basic materials space include L.B. Foster (FSTR - Free Report) , carrying a Zacks Rank #1 (Strong Buy), and Koppers Holding Inc. (KOP - Free Report) and Linde Plc (LIN - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for L.B. Foster’s current-year earnings has been revised 47.4% upward in the past 60 days. The consensus estimate for current-year earnings for FSTR is currently pegged at 53 cents, indicating year-over-year growth of 112.5%. The company’s shares have popped around 12% over the past year. FSTR beat the Zacks Consensus Estimate in all the last four quarters. It delivered a trailing four-quarter earnings surprise of 140.5%, on average.
The Zacks Consensus Estimate for Koppers’ current-year earnings is currently pegged at $4.40, implying year-over-year growth of 6.3%. It delivered a trailing four-quarter earnings surprise of roughly 13.64%, on average. Shares of KOP have gained 32% in a year.
The Zacks Consensus Estimate for Linde’s current-year earnings has been revised 5.1% upward in the past 60 days. LIN beat the Zacks Consensus Estimate in all the last four quarters, with an average earnings surprise being 6.9%. The company’s shares have gained 22.5% in the past year.